Key result
Ruptured abdominal aortic aneurysms exhibited a specific molecular fingerprint, including 5 genes linked to terminal progression and 5 genes exclusively upregulated in ruptured aneurysms.
Why the study?
What are the specific molecular changes and gene expression profiles associated with terminal progression and rupture of abdominal aortic aneurysms?
Observational (n=112)
What are the specific molecular changes and gene expression profiles associated with terminal progression and rupture of abdominal aortic aneurysms?
Terminal abdominal aortic aneurysm disease and rupture are associated with a specific molecular fingerprint characterized by the activation of HIF-1α signaling in mesenchymal cells, offering potential targets for rupture risk assessment.
May support molecular rupture-risk biomarkers in AAA; cross-sectional data leave causal roles and therapeutic targets open.
Background Clinical decision making in abdominal aortic aneurysms (AAA) relies completely on diameter. At this point, improved decision tools remain an unmet medical need. Our goal was to identify changes at the molecular level specifically leading up to AAA rupture. Methods and Results Aortic wall tissue specimens were collected during open elective (e AAA ; n=31) or emergency repair of ruptured AAA (r AAA ; n=17), and gene expression was investigated using microarrays. Identified candidate genes were validated with quantitative real‐time polymerase chain reaction in an independent sample set (e AAA : n=46; r AAA : n=18). Two gene sets were identified, 1 set containing 5 genes linked to terminal progression, that is, positively associated with progression of larger AAA , and with rupture ( HILPDA , ANGPTL 4 , LOX , SRPX 2 , FCGBP ), and a second set containing 5 genes exclusively upregulated in rAAA ( ADAMTS 9 , STC 1 , GFPT 2 , GAL 3 ST 4 , CCL 4L1 ). Genes in both sets essentially associated with processes related to impaired tissue remodeling, such as angiogenesis and adipogenesis. In gene expression experiments we were able to show that upregulated gene expression for identified candidate genes is unique for AAA . Functionally, the selected upregulated factors converge at processes coordinated by the canonical HIF ‐1α signaling pathway and are highly expressed in fibroblasts but not inflammatory cells of the aneurysmatic wall. Histological quantification of angiogenesis and exploration of the HIF ‐1α network in r AAA versus e AAA shows enhanced microvessel density but also clear activation of the HIF ‐1α network in r AAA . Conclusions Our study shows a specific molecular fingerprint for terminal AAA disease. These changes appear to converge at activation of HIF ‐1α signaling in mesenchymal cells. Aspects of this cascade might represent targets for rupture risk assessment.
No takes yet. Share an insight, caveat, or question.
Gäbel et al. (2017) conducted an observational in Abdominal aortic aneurysms (AAA) (n=112). Ruptured abdominal aortic aneurysm vs. Elective repair of unruptured abdominal aortic aneurysm was evaluated on Gene expression changes (molecular fingerprint) associated with AAA rupture. Ruptured abdominal aortic aneurysms exhibited a specific molecular fingerprint, including 5 genes linked to terminal progression and 5 genes exclusively upregulated in ruptured aneurysms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: